Wako Diagnostics is a brand of in vitro diagnostics products promoted by Wako Life Sciences, Inc. The main product lines were first introduced with the flagship IVD test system, μTASWako® i30, launched in 2011 for the liver cancer market. We also have "best in class" reagents for clinical chemistry and research laboratories.
Wako Life Sciences, Inc.
Wako Life Sciences, Inc. is a wholly owned subsidiary of Wako Pure Chemical Industries, Ltd. of Japan, worldly renowned for its high quality chemicals. Wako Life Sciences, Inc. was established in 2012 to focus on the development, marketing, and sales of in vitro diagnostic products branded as Wako Diagnostic in North/South America. The mission of Wako Life Sciences is to develop and supply In-Vitro Diagnostic and Life Science products to our valued clients for the improvement of patient survival and quality of life through innovative and technological solutions. Wako Life Sciences, Inc. is headquartered in Mountain View, CA and has R&D facilities and commercial operations in Mountain View and Richmond, VA.
Wako Pure Chemical Industries, Ltd.
Wako Pure Chemical Industries, Ltd. has been engaged in the development and manufacture of high-quality products as a comprehensive reagent manufacturer capable of responding to research needs in cutting-edge areas. At present, Wako uses our unique technological capabilities - Wako's core competence - to focus on three key operational areas, Laboratory Chemicals, Specialty Chemicals, and Diagnostic Reagents, and to meet the diverse requirements of researchers, medical professionals and industry.
- Visit "Wako Pure Chemical Industries" website.